Researchers at Waypoint Centre for Mental Health Care and Sunnybrook Health Sciences Centre are exploring whether a non-invasive brain stimulation can help reduce smoking cravings and support quitting.
Individuals who are motivated to quit smoking are invited to participate in a clinical trial that could help reduce cravings and support smoking cessation.
Researchers will evaluate the feasibility, safety and effectiveness of accelerated deep transcranial magnetic stimulation (aTMS) delivered in a short, five-day schedule. Participants will receive onsite treatment (approximately three hours per day) at Waypoint or Sunnybrook, followed by five follow-up visits over the course of six months.
How it works:
The treatment uses a Health Canada-approved device that delivers magnetic pulses to target areas of the brain involved in nicotine cravings — no medication or anesthesia required. Many participants find the procedure well-tolerated, with only mild side effects like a temporary headache or scalp discomfort.
This clinical trial is one of the first at Waypoint and offers a promising alternative to traditional smoking cessation methods. Financial compensation is provided for participation.
Eligibility requirements:
• Must be aged 18 years or older
• Regular smoker
• Motivated to quit or reduce smoking
Interested in participating?
If you are interested in joining this study, please reach out for more information by emailing rtms.smoking@waypointcentre.ca.
